Asset
ABEXINOSTAT
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01149668 | phase1 | completed | 2010-06-01 | 2012-12-01 | Pharmacyclics LLC. | A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer |
| NCT00562224 | phase1 | completed | 2007-11-01 | 2010-06-01 | Pharmacyclics LLC. | Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients |
| NCT00724984 | phase1_2 | completed | 2008-07-01 | 2012-11-01 | Pharmacyclics LLC. | Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma |
| NCT00473577 | phase1 | completed | 2005-08-01 | 2007-11-01 | Pharmacyclics LLC. | Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients |
FDA applications (0)
This company has no applications containing this asset.